New in 2013
NEW IN 2013 BY ATTENDEE REQUEST:
- Conference sessions will take place in re-designed exhibit halls to bring buyers and suppliers together all day, every day
- 3 full days instead of 4 (September 17-19, 2013)
- Portable meeting rooms in exhibit halls for exclusive exhibitor use only
- Exhibit Hall roundtables, reception, raffles, and other ongoing activities all day, every day, to attract attendees
- New, business-critical topics for panels and talks
- More stand alone talks and high profile keynote speakers
- One day low cost pass to attract new participants
- One week later than usual to attract more attendees
- Lower rate for Pharmaceutical Co. end users and other "buyers"
ChemOutsourcing is the largest USA-based API show attracting annually 700-800 chemists from the pharmaceutical, biotech, and chemical industries. The show focuses on API development spanning early drug discovery through chemical development and commercial supply. Attendees are executive scientists from pharmaceutical companies responsible for sourcing starting materials, intermediates, and Active Ingredients, and experienced in working with Contract Research and Contract Manufacturing Organizations. Likewise, the show is heavily attended by high-level executive suppliers of these services and products, including 100+ exhibitors. The show is further distinguished by its accessible buyers and upscale seaside venue.
ChemOutsourcing in the News!
- 2013: A Simple Guide to Vendor Shows ChemOutsourcing in the News!
- ChemOutsourcing 2010: The Meeting Point of Major Players
- A Rookie's Experience at Pharma ChemOutsourcing 2012
Thursday, May 25, 2013, List of Buyer Companies Already Registered to Attend
|
Abbott Labs AbbVie (5) Aegerion Pharmaceuticals (2) Alvogen Amicus Therapeutics (2) Amgen (3) Ariad Pharmaceuticals Arno Therapeutics ArQule Array BioPharma AstraZeneca Neuroscience AstraZeneca Pharmaceuticals Axikin Pharmaceuticals Bayer Healthcare BioNumerick Pharmaceuticals Bristol-Myers Squibb (10) Boehringer Ingelheim Pharmaceuticals (4) Cardioxyl Pharmaceuticals Celgene Corporation Celgene Avilomics Research Concert Pharmaceuticals, Inc. Cubist Pharmaceuticals (2) Curis, Inc. Cytokinetics DuPont Crop Protection Eli Lilly & Company (4) Ember Therapeutics Exelixis, Inc. F. Hoffmann-La Roche Fibrogen, Inc. Forest Labs (2) Galleon Pharmaceuticals Genentech (3) Gilead Sciences (3) GlaxoSmithKline (4) GlycoMimetics, Inc Grunental GmbH |
Idenix Pharmaceuticals (2) Ikaria Impax Laboratories Incyte Corporation InterMune Ironwood Pharmaceuticals (2) Intrexon Corporation Janssen R&D (2) Johnson & Johnson (3) Kadmon Corporation Keryx Biopharmaceuticals (2) Lantheus Medical Imaging Lexicon Pharmaceuticals MedImmune, Inc. Medivation, Inc. Merck & Company (8) Merck Sharp & Dohme Merck Animal Health Millenium Pharmaceuticals Mylan Pharmaceuticals Neurocrine Biosciences Novartis Pharmaceuticals (3) NPS Pharmaceuticals PTC Therapeutics (2) Pfizer (7) Pharmacyclics, Inc. Purdue Pharma (2) Rib-X Pharmaceuticals Roche pRED China Sanofi Aventis Deutschland Sanofi Aventis USA Sanofi Pasteur Sartori Pharmaceuticals Shionogi, Inc Shire Pharmaceuticals Sunovion Pharmaceuticals Takeda San Diego, Inc Tarsa Therapeutics TetraPhase Pharmaceuticals (2) Teva Pharmaceuticals (2) Thervance TransTech Pharma Trius Therapeutics UCB Pharma United Therapeutics (5) Vertex Pharmaceuticals |